Pró-fármaco ativado por enzima, uma estratégia promissora na quimioterapia



Document title: Pró-fármaco ativado por enzima, uma estratégia promissora na quimioterapia
Journal: Quimica nova
Database: PERIÓDICA
System number: 000313220
ISSN: 0100-4042
Authors: 1

Institutions: 1Universidade Estadual Paulista "Julio de Mesquita Filho", Faculdade de Ciencias Farmaceuticas, Araraquara, Sao Paulo. Brasil
Year:
Season: Nov
Volumen: 29
Number: 6
Pages: 1307-1317
Country: Brasil
Language: Portugués
Document type: Artículo
Approach: Experimental, aplicado
English abstract Strategies that promote selective activation of prodrugs by enzymes can be divided into two major classes: 1) deliver of a monoclonal antibody-enzyme immunoconjugate that can recognize a specific antigen and promote the prodrug to a citotoxic drug, with a high selectivity for the target cells, and 2) selective gene delivery encoding an enzyme that can promote the prodrug to a citotoxic drug for the target cells. In this article are discussed ADEPT (antibody-directed enzyme prodrug therapy), GDEPT (gene-directed enzyme prodrug therapy), VDEPT (virus-directed enzyme prodrug therapy), GPAT (genetic prodrug activation therapy) and PDEPT (polymer-directed enzyme prodrug therapy) approaches, their clinical trials, advantages, disadvantages and perspectives
Disciplines: Química,
Medicina
Keyword: Química farmacéutica,
Oncología,
Profármacos,
Cáncer,
Activación enzimática,
Quimioterapia
Keyword: Chemistry,
Medicine,
Medicinal chemistry,
Oncology,
Prodrugs,
Cancer,
Enzymatic activation,
Chemotherapy
Full text: Texto completo (Ver HTML)